Clinical trial
Predischarge Initiation of Ivabradine in the Management of Heart Failure (PRIME-HF)
NCT02827500 is registered in ClinicalTrials.gov with Duke University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Predischarge Initiation of Ivabradine in the Management of Heart Failure (PRIME-HF)
- Lead sponsor
- Duke University
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- July 31, 2016
- Completion date
- October 15, 2018
- Enrollment
- 104 (actual)
- Sites
- 20
Conditions
As the registry lists them; a condition with its own page is linked.